Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

[An alarming threat to secondary prevention: low compliance (lifestyle) and poor adherence (drugs)].

Fuster V.

Rev Esp Cardiol (Engl Ed). 2012 Jul;65 Suppl 2:10-6. Review. Spanish.

PMID:
22921169
2.

Aiming at strategies for a complex problem of medical nonadherence.

Castellano JM, Copeland-Halperin R, Fuster V.

Glob Heart. 2013 Sep;8(3):263-71. doi: 10.1016/j.gheart.2013.06.001. Epub 2013 Sep 26.

PMID:
25690505
3.

[Polytherapy in cardiovascular prevention: open issues].

Volpe M, Pignatelli G, Paneni F.

G Ital Cardiol (Rome). 2012 Jul-Aug;13(7-8):503-10. doi: 10.1714/1114.12246. Review. Italian.

PMID:
22781377
4.

Reducing residual risk: modern pharmacochemistry meets old-fashioned lifestyle and adherence improvement.

Kones R.

Ther Adv Cardiovasc Dis. 2013 Jun;7(3):169-82. doi: 10.1177/1753944712467828. Epub 2013 Feb 6. Review.

PMID:
23389677
5.

Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence.

Daviglus ML, Lloyd-Jones DM, Pirzada A.

Am J Cardiovasc Drugs. 2006;6(2):87-101. Review.

PMID:
16555862
6.
7.

Polypill and global cardiovascular health strategies.

Sanz G, Fuster V.

Semin Thorac Cardiovasc Surg. 2011 Spring;23(1):24-9. doi: 10.1053/j.semtcvs.2011.05.005. Review.

PMID:
21807295
9.
10.

[Therapeutic alliance, a stake in schizophrenia].

Charpentier A, Goudemand M, Thomas P.

Encephale. 2009 Feb;35(1):80-9. doi: 10.1016/j.encep.2007.12.009. Epub 2008 May 19. Review. French.

PMID:
19250998
11.

Toward the realization of a better aged society: messages from gerontology and geriatrics.

Arai H, Ouchi Y, Yokode M, Ito H, Uematsu H, Eto F, Oshima S, Ota K, Saito Y, Sasaki H, Tsubota K, Fukuyama H, Honda Y, Iguchi A, Toba K, Hosoi T, Kita T; Members of Subcommittee for Aging.

Geriatr Gerontol Int. 2012 Jan;12(1):16-22. doi: 10.1111/j.1447-0594.2011.00776.x. Review.

PMID:
22188494
12.

The fixed-dose combination drug for secondary cardiovascular prevention project: improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives.

Sanz G, Fuster V, Guzmán L, Guglietta A, Arnáiz JA, Martínez F, Sarria A, Roncaglioni MC, Taubert K.

Am Heart J. 2011 Nov;162(5):811-817.e1. doi: 10.1016/j.ahj.2011.08.012.

PMID:
22093195
13.

Surveillance of certain health behaviors and conditions among states and selected local areas --- Behavioral Risk Factor Surveillance System, United States, 2009.

Li C, Balluz LS, Okoro CA, Strine TW, Lin JM, Town M, Garvin W, Murphy W, Bartoli W, Valluru B; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2011 Aug 19;60(9):1-250.

14.

[Therapeutic non-compliance: a major problem in the prevention of cardiovascular diseases].

Scheen AJ.

Rev Med Liege. 1999 Dec;54(12):914-20. French.

PMID:
10686796
15.

The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence.

Jolly K, Taylor R, Lip GY, Greenfield S, Raftery J, Mant J, Lane D, Jones M, Lee KW, Stevens A.

Health Technol Assess. 2007 Sep;11(35):1-118. Review.

16.

A polypill strategy to improve global secondary cardiovascular prevention: from concept to reality.

Castellano JM, Sanz G, Fernandez Ortiz A, Garrido E, Bansilal S, Fuster V.

J Am Coll Cardiol. 2014 Aug 12;64(6):613-21. doi: 10.1016/j.jacc.2014.06.009. Review. Erratum in: J Am Coll Cardiol. 2014 Oct 7;64(14):1539.

17.

Optimal medical therapy, lifestyle intervention, and secondary prevention strategies for cardiovascular event reduction in ischemic heart disease.

Joseph P, Teo K.

Curr Cardiol Rep. 2011 Aug;13(4):287-95. doi: 10.1007/s11886-011-0190-5. Review.

PMID:
21556974
18.

Prevalence of selected risk behaviors and chronic diseases and conditions-steps communities, United States, 2006-2007.

Cory S, Ussery-Hall A, Griffin-Blake S, Easton A, Vigeant J, Balluz L, Garvin W, Greenlund K; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2010 Sep 24;59(8):1-37.

20.

[Modifying habits and treatment adherence, essential for controlling the chronic disease].

Pisano González MM, González Pisano A.

Enferm Clin. 2014 Jan-Feb;24(1):59-66. doi: 10.1016/j.enfcli.2013.10.006. Epub 2013 Dec 24. Spanish.

PMID:
24369770

Supplemental Content

Support Center